Taiwan Journal of Ophthalmology最新文献

筛选
英文 中文
Corneal transplantation surgery: Where we are and where are we going? 角膜移植手术:我们的现状和未来?
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-03-15 eCollection Date: 2024-01-01 DOI: 10.4103/tjo.TJO-D-24-00009
Jorge L Alio
{"title":"Corneal transplantation surgery: Where we are and where are we going?","authors":"Jorge L Alio","doi":"10.4103/tjo.TJO-D-24-00009","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-24-00009","url":null,"abstract":"","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic treatment and surgical intervention in inflammatory Terrien disease. 炎症性特里恩病的系统治疗和手术干预。
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-03-15 eCollection Date: 2024-01-01 DOI: 10.4103/tjo.TJO-D-23-00176
Francisco Arnalich-Montiel
{"title":"Systemic treatment and surgical intervention in inflammatory Terrien disease.","authors":"Francisco Arnalich-Montiel","doi":"10.4103/tjo.TJO-D-23-00176","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00176","url":null,"abstract":"<p><p>This case report presents a unique instance of a 55-year-old male patient exhibiting features of both Terrien marginal degeneration (TMD) and Fuchs' superficial marginal keratitis. Characterized by peripheral corneal thinning vascularization, and a pseudopterygium, the patient experienced recurrent photophobia, redness, and tearing over 15 years. This case challenges the traditional distinction between TMD and Fuchs' superficial marginal keratitis, suggesting a potential common underlying disorder. Mycophenolate mofetil provided a partial response, while pseudopterygium removal led to sustained remission, emphasizing its therapeutic significance. This case highlights the first documented use of mycophenolate in TMD and supports the notion of shared vasculitic origins between TMD and Fuchs' keratitis, raising intriguing questions about targeted therapeutic interventions.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-Descemet's endothelial keratoplasty with glued intraocular lens implantation with pinhole pupilloplasty in a case of ocular comorbidity in achromatopsia. 在一例无色素性视网膜病变患者的眼部合并症中,采用前去角皮内皮角膜移植术和针孔瞳孔成形术植入胶合型人工晶体。
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-03-15 eCollection Date: 2024-01-01 DOI: 10.4103/tjo.TJO-D-23-00172
Dhivya Ashok Kumar, Amar Agarwal, Swetha Ravichandran
{"title":"Pre-Descemet's endothelial keratoplasty with glued intraocular lens implantation with pinhole pupilloplasty in a case of ocular comorbidity in achromatopsia.","authors":"Dhivya Ashok Kumar, Amar Agarwal, Swetha Ravichandran","doi":"10.4103/tjo.TJO-D-23-00172","DOIUrl":"https://doi.org/10.4103/tjo.TJO-D-23-00172","url":null,"abstract":"<p><p>Ocular comorbidities can happen as congenital defective gene associations. We present a 37-year-old female patient who was mentally challenged and had coexisting achromatopsia gene abnormality on genetic analysis. She was operated in childhood for congenital cataract, and posterior chamber intraocular lens (IOL) was implanted at 10 years of age elsewhere. The patient presented 27 years later with luxated IOL with endothelial decompensation. There was a coexisting steep and thin cornea noted on corneal topography. She was managed with pre-Descemet's endothelial keratoplasty with transpositioning of posterior chamber IOL to glued IOL with single-pass four-throw pupilloplasty. Postoperatively, the cornea was clear with centered glued IOL. The lesser postanesthetic challenges and faster rehabilitation are obtained in combination procedures with reduced complications in such rare scenarios.</p>","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Main issues in penetrating keratoplasty 穿透性角膜移植术的主要问题
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-29 DOI: 10.4103/tjo.tjo-d-24-00001
Jorge L. Alió, Sana Niazi, Farideh Doroodgar, J. D. Barrio, Hassan Hashemi, Mohammad Ali Javadi
{"title":"Main issues in penetrating keratoplasty","authors":"Jorge L. Alió, Sana Niazi, Farideh Doroodgar, J. D. Barrio, Hassan Hashemi, Mohammad Ali Javadi","doi":"10.4103/tjo.tjo-d-24-00001","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-24-00001","url":null,"abstract":"\u0000 This review explores contemporary challenges in penetrating keratoplasty (PK), focusing on technical intricacies, technological advancements, and strategies for preventing graft rejection. A systematic literature search from January 2018 to July 2023 was conducted across PubMed, Cochrane, Web of Science, Scopus, and EMBASE. The inclusion criteria comprised studies on PK and its comparison with other corneal pathologies, with emphasis on keratoconus (KC). Two independent reviewers screened studies, extracting relevant data. The review covers PK evolution, highlighting infra-red femtosecond lasers’ impact on graft shapes, minimizing astigmatism, and enhancing wound healing. Graft rejection, a primary complication, is examined, detailing risk factors and preventive measures. Preoperative considerations, diagnostic techniques for rejection, and PK in KC are discussed. Postoperative care’s significance, including intraocular pressure monitoring and steroid administration, is emphasized. The paper concludes with a comprehensive approach to prevent graft rejection, involving topical and systemic medications. An outlook on evolving monoclonal antibody research is presented. As the field progresses, personalized approaches and ongoing therapeutic exploration are expected to refine strategies, enhancing PK outcomes.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140413976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral keratitis associated with afatinib therapy 与阿法替尼治疗相关的双侧角膜炎
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-23 DOI: 10.4103/tjo.tjo-d-24-00003
Ya-Tung Liu, Chen-Wei Lin, Chi-Chin Sun, Shih-Chieh Shao, Nan-Ni Chen
{"title":"Bilateral keratitis associated with afatinib therapy","authors":"Ya-Tung Liu, Chen-Wei Lin, Chi-Chin Sun, Shih-Chieh Shao, Nan-Ni Chen","doi":"10.4103/tjo.tjo-d-24-00003","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-24-00003","url":null,"abstract":"\u0000 This case discussed a significant ocular side effect, bilateral keratitis, which could be induced by afatinib, an irreversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI). We explored the disease progression of a 52-year-old, stage IV nasopharyngeal carcinoma male patient, who was under afatinib treatment and had experienced progressive bilateral eye dryness and tenderness on increasing afatinib from 40 mg every other day to 40 mg daily. Clinical examination noted bilateral visual acuity reduction, diffuse superficial punctate keratopathy in the right eye, and a central epithelial defect in the left eye. Seidel test results were negative for both eyes, with no corneal infiltration, lagophthalmos, anterior chamber cell precipitation, or retinal lesion. Symptoms subsequently resolved after reducing the frequency of afatinib used, along with intensive ocular hydration. In summary, this case highlighted afatinib’s potential link to bilateral keratitis, and early afatinib dose adjustment with supportive medication could significantly reverse the condition.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140436559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Main issues in deep anterior lamellar keratoplasty: A systematic narrative review 深前板层角膜移植术的主要问题:系统性叙述回顾
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-23 DOI: 10.4103/tjo.tjo-d-23-00175
Sana Niazi, J. D. Barrio, Farideh Doroodgar, Mohammad Ali Javadi, Jorge L. Alió
{"title":"Main issues in deep anterior lamellar keratoplasty: A systematic narrative review","authors":"Sana Niazi, J. D. Barrio, Farideh Doroodgar, Mohammad Ali Javadi, Jorge L. Alió","doi":"10.4103/tjo.tjo-d-23-00175","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00175","url":null,"abstract":"\u0000 Deep anterior lamellar keratoplasty (DALK) has emerged as a transformative approach in managing corneal pathologies, notably keratoconus (KC), providing a viable alternative to penetrating keratoplasty (PK). This systematic review explores the intricacies of DALK, comparing its preoperative, intraoperative, and postoperative considerations with PK. Extensive literature searches revealed a wealth of data regarding DALK’s advantages and challenges, with an emphasis on graft survival, visual outcomes, and complications. In the preoperative phase, DALK showcases its versatility, catering to a wide spectrum of patients, including those with KC and ocular surface disorders. Intraoperatively, it offers innovative techniques to address emphysema, bubble formation, and Descemet’s membrane perforation, all while maintaining a strong focus on patient-centered outcomes. Postoperatively, DALK’s lower rejection rates and decreased complications underscore its potential superiority over PK, although unique challenges such as graft failure from nonimmunologic factors demand vigilant management. This comprehensive review not only serves as a valuable resource for ophthalmic surgeons but also sheds light on the evolving landscape of corneal transplantation, highlighting DALK’s role as a transformative force in the field.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140438048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of 320-degree intrastromal corneal ring segment implantation for advanced keratoconus 320 度角膜环植入术治疗晚期角膜炎的效果
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-23 DOI: 10.4103/tjo.tjo-d-24-00004
Nan-Ni Chen, Chi-Chin Sun
{"title":"Outcomes of 320-degree intrastromal corneal ring segment implantation for advanced keratoconus","authors":"Nan-Ni Chen, Chi-Chin Sun","doi":"10.4103/tjo.tjo-d-24-00004","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-24-00004","url":null,"abstract":"\u0000 \u0000 \u0000 The purpose of this study is to investigate visual and tomographic outcomes and complications of long-arc length intrastromal corneal ring segment (ICRS) implantation for the treatment of advanced keratoconus.\u0000 \u0000 \u0000 \u0000 This retrospective study enrolled 10 eyes of 9 subjects. All patients received 320-degree ICRS (320-ICRS) implantation with femtosecond laser-assisted technique based on their advanced grading with preoperative high keratometry (K) value, asphericity (Q), and astigmatism. Medical records and corneal tomography changes of consecutive patients were reviewed at baseline, 1, and 3 months after treatment.\u0000 \u0000 \u0000 \u0000 There are 6 female and 3 male patients with a mean age of 29.6 ± 7.8 years in this study. Mean K (Km) reduced from 59.01 ± 5.81 D preoperatively to 50.7 ± 5.3 and 50.2 ± 3.66 postoperatively (after 1 month and 3 months respectively, P < 0.001). The changes in mean K, K1, K2, and maximum K (Kmax) reading were all statistically significant (all P < 0.001). Mean uncorrected distance visual acuity (UCVA) improved from 20/400 to 20/200. Mean best-corrected distance visual acuity (BCVA) improved from 20/100 to 20/60. Both UCVA and BCVA showed a trend of improvement at postoperative month 3, though insignificant in BCVA (P = 0.114). Mean Q improved from −1.59 ± 0.62 preoperatively to −0.48 ± 1.08 and −0.11 ± 1.04 postoperatively (after 1 month and 3 months respectively, P = 0.016, 0.002). No intraoperative or postoperative complications were observed.\u0000 \u0000 \u0000 \u0000 The present results suggest that implanting a 320-ICRS is a safe and effective procedure for treating patients with advanced keratoconus. Preoperative corneal measurements and the selection of types and thickness of ICRS are important to prevent unpredictable results.\u0000","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140437176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large-diameter deep anterior lamellar keratoplasty: A narrative review 大直径深前板层角膜移植术:叙述性综述
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-23 DOI: 10.4103/tjo.tjo-d-23-00161
A. C. Yu, Andrea Sollazzo, Cristina Bovone, Massimo Busin
{"title":"Large-diameter deep anterior lamellar keratoplasty: A narrative review","authors":"A. C. Yu, Andrea Sollazzo, Cristina Bovone, Massimo Busin","doi":"10.4103/tjo.tjo-d-23-00161","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00161","url":null,"abstract":"\u0000 Deep anterior lamellar keratoplasty (DALK) involves the selective replacement of diseased corneal stroma while preserving healthy unaffected endothelium. While DALK has failed to gain widespread popularity, improved visual and refractive outcomes of large-diameter grafts, which patients directly perceive following suture removal, may represent a compelling reason to shift toward DALK. Since the unaffected host endothelium is retained, DALK offers the opportunity to use large-diameter grafts, which reliably achieves maximum visual potential without an increased risk of immune-mediated stromal rejection. In this narrative review, we evaluate the current evidence on large-diameter DALK including surgical technique and clinical outcomes.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140438432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomechanical changes in keratoconus after customized stromal augmentation 定制基质增强术后角膜炎的生物力学变化
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-20 DOI: 10.4103/tjo.tjo-d-23-00155
Sana Niazi, J. A. D. del Barrio, Farideh Doroodgar, Azad Sanginabadi, C. Alinia, S. J. Hashemian, Hassan Hashemi, Jorge L. Alió
{"title":"Biomechanical changes in keratoconus after customized stromal augmentation","authors":"Sana Niazi, J. A. D. del Barrio, Farideh Doroodgar, Azad Sanginabadi, C. Alinia, S. J. Hashemian, Hassan Hashemi, Jorge L. Alió","doi":"10.4103/tjo.tjo-d-23-00155","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00155","url":null,"abstract":"\u0000 \u0000 \u0000 To verify corneal biomechanical changes, poststromal augmentation using myopic small-incision lenticule extraction’s (SMILEs) lenticules in advanced keratoconus (KCN) through Corvis ST (Oculus, Wetzlar, Germany).\u0000 \u0000 \u0000 \u0000 A clinical trial enrolled 22 advanced KCN patients. We implanted lenticules exceeding 100 μ according to a nomogram and evaluated biomechanical factors through Corvis ST at 3-, 6-, and 24-month postimplantation. We examined parameters during the first applanation (A1), second applanation (A2), highest concavity (HC)/max concavity events, and Vinciguerra screening parameters, as recently established criteria derived from the ideal blend of diverse biomechanical and ocular factors and formulated through the application of logistic regression. Regression analyses explored relationships with age, mean keratometry value, thickness, sphere, cylinder, and best-corrected visual acuity.\u0000 \u0000 \u0000 \u0000 Patients were well matched for age, intraocular pressure, and central corneal thickness (CCT). The mean spherical equivalent decreased from −13.48 ± 2.86 Diopters (D) to −8.59 ± 2.17 D (P < 0.007), and mean keratometry decreased from 54.68 ± 2.77 D to 51.95 ± 2.21 D (P < 0.006). Significant increases were observed in HC time (HCT), Radius–central curvature radius at the HC state–, peak distance (PD) during HC state, CCT, first applanation time, and stiffness parameter (A1T and SP-A1), whereas HC deformation amplitude, maximum deformation amplitude ratio at 2 mm, Corvis Biomechanical Index (CBI), integrated radius (IR), second applanation deformation amplitude (A2DA), first applanation velocity and deflection amplitude (A1V and A1DeflA) significantly decreased postlenticule implantation. Multivariable regression revealed age positively correlated with SP-A1 (P = 0.003) and negatively with HC delta Arc length (P = 0.007). Mean K positively correlated with CCT (P = 0.05) and negatively with CBI (P = 0.032). Best-corrected visual acuity positively correlated with HCT (P = 0.044), and the cylinder positively correlated with PD (P = 0.05) and CCT (P = 0.05) whereas negatively with IR (P = 0.025).\u0000 \u0000 \u0000 \u0000 Stromal augmentation using myopic SMILE lenticules induces significant corneal biomechanical changes in KCN.\u0000","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140448851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the efficacy of Rho kinase inhibitor eye drops in the management of corneal edema: A single-center retrospective cohort study 评估 Rho 激酶抑制剂滴眼液治疗角膜水肿的疗效:单中心回顾性队列研究
IF 1.1
Taiwan Journal of Ophthalmology Pub Date : 2024-02-20 DOI: 10.4103/tjo.tjo-d-23-00169
Itay Lavy, N. Erdinest, Jamel Corredores, Denise Wajnsztajn, David Smadja
{"title":"Evaluating the efficacy of Rho kinase inhibitor eye drops in the management of corneal edema: A single-center retrospective cohort study","authors":"Itay Lavy, N. Erdinest, Jamel Corredores, Denise Wajnsztajn, David Smadja","doi":"10.4103/tjo.tjo-d-23-00169","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00169","url":null,"abstract":"\u0000 \u0000 \u0000 This study aimed to evaluate the efficacy of ripasudil in managing various corneal edema conditions.\u0000 \u0000 \u0000 \u0000 This single-center retrospective analysis was conducted at Hadassah Medical Center and involved 16 patients with 17 eyes. Patients were selected based on diagnostic criteria, primarily corneal edema. The conditions were as follows, listed by frequency: postcataract surgery (31.25%), postpenetrating keratoplasty (25%), post-Descemet’s membrane endothelial keratoplasty (18.75%), Fuchs’ endothelial corneal dystrophy (12.5%), status post-Ahmed glaucoma valve (6.25%), and status posttrabeculectomy (6.25%). The treatment regimen involved topical administration of ripasudil hydrochloride hydrate (Glanatec® 0.4%), administered three times a day or tailored to condition severity. Efficacy was assessed using pre- and posttreatment measurements of best-corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell count (ECC), along with slit-lamp and optical coherence tomography examinations.\u0000 \u0000 \u0000 \u0000 The average duration of ripasudil treatment was approximately 4.9 ± 2.2 months. Significant improvements were observed in BCVA, changing from a pretreatment value of 1.106 ± 0.817 logMAR to a posttreatment value of 0.56 ± 0.57 logMAR (P = 0.0308). CCT also showed a significant reduction, from 619.50 ± 56.36 μm pretreatment to 572.5 ± 75.48 μm posttreatment (P = 0.0479). ECC showed a marginal but not statistically significant increase, from 849.00 ± 570.72 cells/mm² pretreatment to 874.75 ± 625.59 cells/mm² posttreatment (P = 0.9010).\u0000 \u0000 \u0000 \u0000 The study provides robust evidence supporting the use of ripasudil in managing corneal edema. Significant improvements in key ocular metrics such as BCVA and CCT were observed, enhancing the overall quality of life for patients suffering from various forms of corneal edema.\u0000","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140446939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信